What is CND Life Sciences?
Founded in 2017, CND Life Sciences operates within the dynamic medtech sector, dedicating its research and development efforts to pioneering solutions for neurodegenerative disorders. The company's strategic focus on this complex area of medicine positions it at the forefront of therapeutic innovation, aiming to develop groundbreaking treatments and diagnostic tools. The recent influx of capital is expected to accelerate its product development pipeline and expand its research capabilities.
How much funding has CND Life Sciences raised?
CND Life Sciences has raised a total of $26M across 2 funding rounds:
Angel/Seed
$12.5M
Series A
$13.5M
Angel/Seed (2023): $12.5M, investors not publicly disclosed
Series A (2025): $13.5M led by Tanis Ventures, Cambrian Capital Partners, and BlueStone Ventures
Key Investors in CND Life Sciences
Tanis Ventures
Tanis Ventures is a company in the process of launching new products or services, anticipated to offer significant impact. They appear focused on innovation and creating impactful solutions.
Cambrian Capital Partners
Cambrian Capital specializes in off-market and innovative investment solutions for private capital, assisting with funding, succession planning, and data-driven growth strategies across various business sectors.
BlueStone Ventures
BlueStone Ventures is a construction and development company known for delivering quality work with personalized service, managing projects from planning to execution with attention to detail.
What's next for CND Life Sciences?
With this major enterprise-level funding, CND Life Sciences is poised for significant expansion and advancement. The strategic investment signals a strong belief in the company's long-term vision and its potential to make a substantial impact on the treatment of neurodegenerative diseases. Future endeavors will likely involve scaling up clinical trials, enhancing research infrastructure, and potentially forging strategic partnerships to bring its innovative therapies to market. This capital injection is a critical catalyst for CND Life Sciences to achieve its next phase of growth and solidify its position in the competitive life sciences landscape.
See full CND Life Sciences company page
